Disseminated epidermolytic acanthoma revealed by PUVA.
Disseminated epidermolytic acanthoma was observed during PUVA therapy in a patient with Sézary syndrome. The majority of the lesions resolved within 5 months after the cessation of therapy. This circumstantial evidence together with our knowledge of the effects of PUVA suggest that the skin lesions were revealed by topical photochemotherapy.
D006801:Humans; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy / Q000009:adverse effects*; D010212:Papilloma / Q000209:etiology*; D012751:Sezary Syndrome / Q000150:complications* / Q000628:therapy; D012878:Skin Neoplasms / Q000209:etiology*